Summary Alveolar bone loss and the duration of untreated disease were compared in 31 patients with lepromatous leprosy. In general, those patients with the longest confirmed untreated disease also had the greatest alveolar bone loss in the anterior maxilla. These data, taken together with previous observations, suggest that early detection and uninterrupted treatment of lepromatous patients will reduce the osseous deformities of the disease.
Skeletal involvement is a serious complication of leprosy manifested as a net loss of skeletal mass,I-5 probably due to an acceleration of bone resorption mediated by osteoclasts and osteolytic osteocytes. 6 Resorption of alveolar bone was first noted by Moller-Christensen2• 7. 8 in maxillae from skeletal remains of Danes with leprosy in medieval Denmark. These observations have been confirmed and extended in contemporary popula tions of patients with leprosy by several investigators.9-1 5 These studies have shown that resorption of the alveolar process in the maxilla is a characteristic manifestation of leprosy.
Previously we have examined alveolar bone loss in leprosy and shown that it is greater in the anterior maxilla than other areas of the jaws, that the amount of bone resorption is greater in patients with lepromatous disease, and that the rate of bone loss in treated patients is surprisingly low. 1 3, 15 These data suggest that the Seang Hoo Nah et al.
greater reduction in alveolar bone height in patients with lepromatous disease is the result of bone lost before treatment is initiated. This investigation compared the magnitude of such bone loss and the duration of untreated disease in 31 patients with lepromatous leprosy.
Material and methods
Thirty-one patients with lepromatous leprosy were selected fr om the patient population at the National Leprosy Control Centre, Sungei Buloh, Malaysia. and by 1949 all patients were being treated with this drug. Using this information and that derived from a detailed medical history, we were able to establish for most patients a reasonable record of the length of recognized but untreated disease and the type and continuity of treatment to the present. Alveolar bone loss in the anterior maxilla, was measured radiographically17 as described previouslyl3 using periapical radiographs taken with the paralleling long-cone technique. I S This method permits the reduction in alveolar bone height interproximally to be expressed as a percentage by subtracting the current bone level, related to the root length of the maxillary incisor, from that present initially, presumed to be the fu ll length of the root to the level of the cemento-enamel junction. I S These data from the detailed medical and treatment histories and measure ments of alveolar bone height were used to examine the potential correlation of alveolar bone loss and the duration of untreated lepromatous disease.
Results
Our observations on each patient are presented in Figure 1 , where the mean maxillary anterior alveolar bone resorption is plotted against the duration of untreated and treated disease. Uncertainty about the time treatment began, as well as regularity of treatment, are indicated by individual symbols. Notice that there is a tendency for greater bone loss to be associated with a longer period of untreated disease. This is best illustrated by the 5 individuals aged 79, 60, 73, 70 and 70 whose bone loss was 14, 15, 28, 38 and 48% and length of untreated disease was 2, 8, 4, greater than 8 and 26 years, respectively. However, this association is not without exception.
These data are summarized in Table 1 . In general, patient age and duration of untreated disease increase with bone loss in categories with more than 1 individual. Edentulous patients were untreated fo r longer than 10 years.
Seang H 00 N ah et al. These data taken together suggest that early detection and treatment of leprosy are effective ways to minimize bone loss and skeletal deformities and that immune dysfunctions in patients with leprosy may protect them from the alveolar bone loss that accompanies the periodontal diseases.15
The cause of the local activation of osteoclasts in alveolar bone of these patients, be it the leprosy bacillus itself or its metabolic products, deserves fu rther study.
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